O Ministry of Health Last week announced the application TrateCov to help doctors diagnose patients with signs COVID-19, suggesting the prescription of the drug based on “strict clinical criteria”. However, the public test version only includes drugs with no scientific evidence against the new coronavirus, such as hydroxychloroquine, ivermectin, and azithromycin.
How TrateCov works by the Ministry of Health
The publicly available TrateCov form has been taken down, but is still available through the Internet Repository. Prior to its deletion, this page was updated with the following warning: “This version of TrateCov as a simulated environment will be available until the registrations of health professionals on that platform are implementation and authentication “.
TrateCov requires some patient data to recommend a treatment. You need to enter your date of birth, weight, height, any comorbidities (such as hypertension, diabetes and asthma) and symptoms (such as fever, headache, or nausea).
Also, notice how many times the person has visited certain places in the past two weeks, including work, public transport, a supermarket, bar, beach, or party.
When this is done, the form will calculate the severity score: if the score is 6 or higher, you should order an RT-PCR test and “start early treatment for COVID-19”.
In the test of TecnoblogTrateCov has proposed a large dose of home remedies, none of which are scientifically proven:
- chloroquine diphosphate 500 mg (total of 6 tablets)
- hydroxychloroquine 200 mg (total of 12 tablets)
- ivermectin 6 mg (total of 30 tablets)
- azithromycin 500 mg (total of 5 tablets)
- doxycycline 100 mg (total of 10 tablets)
- zinc sulfate 30 mg (total 14 tablets)
On Twitter, there were some similar reports, and it wasn’t in vain: developer Joselito Júnior analyzed the page’s source code and Find that chloroquine and similar measures would always be recommended when an early treatment option is available, i.e. when the severity score is greater than or equal to 6.
It’s developer Lucio Maciel’s turn point that this score completely ignores the patient’s clinical data, such as age, weight, comorbidities and external activities – it only takes into account the reported symptoms.
In fact, if you say you weigh 9,000 kg, have all the comorbidities (high blood pressure, obesity, etc.) and have literally attended 1,000 parties in the past two weeks, but don’t point out Symptoms, scores will be low and there will be no hint of early treatment.
The drug is inactive against COVID-19
Ministry of Health TrateCov is testing In Manaus, install tents next to clinics to allow physicians to use this tool when taking care of patients coming up with symptoms of COVID-19. The idea is to extend the application to all medical units in the Amazonas capital; and then, for the whole country.
This Tuesday (19), Brazilian Infectious Diseases Association (SBI) and Brazilian Medical Association (ABM) issue a general note, note that “major medical associations and international public health organizations do not recommend prevention or early treatment with drugs, including Anvisa”.
According to the two units, “the best scientific evidence proves that there is no drug as effective in preventing or ‘early treating’ for COVID-19 to date”. They also criticized “those who deny against vaccines and scientifically proven preventive measures,” such as social isolation and masking.
Last week, Twitter concealed a post by President Jair Bolsonaro to advertise an early antimalarial drug to treat the disease. According to the social network, the message violated the “on disclosing misleading and potentially harmful information regarding COVID-19” rules. Brazil accounts for 10% of all deaths worldwide caused by the new coronavirus (SARS-CoV-2).